June 2026 Arxada announced a strategic agreement with Clorox Healthcare to introduce Quanticare™ technology in Clorox Healthcare HyperOxi Disinfecting Wipes. The collaboration focuses on bringing advanced bleach-free sporicidal disinfectant technology to healthcare facilities in North America for infection prevention applications.
May 2026 Safic-Alcan expanded its specialty chemicals business in India through the acquisition of a majority stake in S.A. Ingredients Private Limited. The acquisition strengthened Safic-Alcan’s life sciences and specialty ingredient distribution capabilities, including access to healthcare-related chemical solutions.
April 2026 The Clorox Company completed the acquisition of GOJO Industries, the manufacturer of Purell® hygiene products. The transaction expanded Clorox’s hygiene and infection prevention portfolio by combining disinfectant, sanitization, and hand hygiene solutions.
March 2026 BASF completed the sale of its Aseptrol® chlorine dioxide technology portfolio to Oxidium Technologies LLC. The divestment transferred ownership of the biocide technology platform, enabling Oxidium to further develop chlorine dioxide-based disinfection solutions for water treatment, healthcare, and industrial applications.